Source: Eur Respir J, 51 (6) 1801058; 10.1183/13993003.01058-2018
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Jessica B. Badlam, Eric D. Austin. Beyond oestrogens: towards a broader evaluation of the hormone profile in pulmonary arterial hypertension. Eur Respir J, 51 (6) 1801058; 10.1183/13993003.01058-2018

Member's Comments

No comment yet.

Related content which might interest you: Complexities of oestradiol pharmacology in pulmonary arterial hypertension Source: Eur Respir J 2013; 41: 1465-1466 Year: 2013 Complexities of oestradiol pharmacology in pulmonary arterial hypertension Source: Eur Respir J 2013; 41: 1466-1467 Year: 2013 Evaluation of thyroid function in pulmonary arterial hypertension Source: International Congress 2017 – PAH and CTEPH Year: 2017 Inhibiting oestrogen signalling in pulmonary arterial hypertension: sex, drugs and research Source: Eur Respir J, 50 (2) 1700983; 10.1183/13993003.00983-2017 Year: 2017 Obesity alters oestrogen metabolism and contributes to pulmonary arterial hypertension Source: Eur Respir J, 53 (6) 1801524; 10.1183/13993003.01524-2018 Year: 2019 Oestrogen and the sexual dimorphism of pulmonary arterial hypertension: a translational challenge Source: Eur Respir J 2013; 41: 1014-1016 Year: 2013 Autoimmunity and pulmonary arterial hypertension: The role of leptin Source: Annual Congress 2011 - Experimental pulmonary hypertension Year: 2011 Long-term outcome in pulmonary arterial hypertension: a plea for earlier parenteral prostacyclin therapy Source: Eur Respir Rev 2009; 18: 253-259 Year: 2009 The future of treatment for pulmonary arterial hypertension Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease Year: 2014 The future of treatment for pulmonary arterial hypertension Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease Year: 2017 The future of treatment for pulmonary arterial hypertension Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease Year: 2012 The future of treatment for pulmonary arterial hypertension Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease Year: 2018 Systemic consequences of pulmonary arterial hypertension Source: International Congress 2019 – State of the art session: Pulmonary vascular diseases Year: 2019 Lower than expected pulsatile pulmonary arterial load in a thromboembolic pulmonary hypertension model Source: International Congress 2018 – Experimental research in pulmonary hypertension Year: 2018 Apelin improves cardiac output in patients with pulmonary arterial hypertension Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights Year: 2015 Leptin signalling system as a target for pulmonary arterial hypertension therapy Source: Eur Respir J 2015; 45: 1066-1080 Year: 2015 Oestrogen inhibition reverses pulmonary arterial hypertension and associated metabolic defects Source: Eur Respir J, 50 (2) 1602337; 10.1183/13993003.02337-2016 Year: 2017 Sex matters in pulmonary arterial hypertension Source: Eur Respir J 2014; 44: 553-554 Year: 2014 Sex and haemodynamics in pulmonary arterial hypertension Source: Eur Respir J 2014; 43: 523-530 Year: 2013